Why Qualigen Therapeutics Inc (NASDAQ: QLGN) At $0.28 Is Worth Your Money?

Qualigen Therapeutics Inc (NASDAQ:QLGN) does about 5.33M shares in volume on a normal day but saw 6950821 shares change hands in Monday trading. The company now has a market cap of 2.69M USD. Its current market price is $0.28, marking a decrease of -0.04% compared to the previous close of $0.28. The 52 week high reached by this stock is $1.26 whilst the lowest price level in 52 weeks is $0.14.

Qualigen Therapeutics Inc (QLGN) has a 20-day trading average at $0.1953 and the current price is -77.79% off the 52-week high compared with 93.17% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.2486 and its 200-day simple moving average is $0.5127. If we look at the stock’s price movements over the week, volatility stands at 30.20%, which decreases to 21.63% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 64.13 to suggest the stock is neutral.

The consensus objective for the share price is $5.00, suggesting that the stock has a potential upside of 94.4% over the period.

Qualigen Therapeutics Inc (QLGN) stock is up 62.45% over the week and 17.61% over the past month. Its price is -49.11% year-to-date and -69.90% over the past year.

To reach the target analysts have set, the stock logically needs to grow 94.4 percent from here.

The company has a return on equity of -1656.23%. The beta has a value of -0.79. Price to sales ratio is 1.65.